Cargando…

NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients

AIM: To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn’s disease (CD) patients in clinical remission. METHODS: Patients with CD in clinical remission or with very low disease activity according to the Crohn’s disease activity index were...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäffler, Holger, Rohde, Maria, Rohde, Sarah, Huth, Astrid, Gittel, Nicole, Hollborn, Hannes, Koczan, Dirk, Glass, Änne, Lamprecht, Georg, Jaster, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859222/
https://www.ncbi.nlm.nih.gov/pubmed/29568200
http://dx.doi.org/10.3748/wjg.v24.i11.1196
_version_ 1783307778065956864
author Schäffler, Holger
Rohde, Maria
Rohde, Sarah
Huth, Astrid
Gittel, Nicole
Hollborn, Hannes
Koczan, Dirk
Glass, Änne
Lamprecht, Georg
Jaster, Robert
author_facet Schäffler, Holger
Rohde, Maria
Rohde, Sarah
Huth, Astrid
Gittel, Nicole
Hollborn, Hannes
Koczan, Dirk
Glass, Änne
Lamprecht, Georg
Jaster, Robert
author_sort Schäffler, Holger
collection PubMed
description AIM: To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn’s disease (CD) patients in clinical remission. METHODS: Patients with CD in clinical remission or with very low disease activity according to the Crohn’s disease activity index were genotyped regarding nucleotide-binding oligomerization domain 2 (NOD2), and PBMCs from wild-type (WT)-NOD2 patients, patients with homozygous or heterozygous NOD2 mutations and healthy donors were isolated for further analysis. The cells were cultured with vitamin D, peptidoglycan (PGN) and lipopolysaccharide (LPS) for defined periods of time before RNA was isolated and subjected to microarray analysis using Clariom S assays and quantitative real-time PCR. NOD2- and disease-specific gene expression profiles were evaluated with repeated measure ANOVA by a general linear model. RESULTS: Employing microarray assays, a total of 267 genes were identified that were significantly up- or downregulated in PBMCs of WT-NOD2 patients, compared to healthy donors after challenge with vitamin D and/or a combination of LPS and PGN (P < 0.05; threshold: ≥ 2-fold change). For further analysis by real-time PCR, genes with known impact on inflammation and immunity were selected that fulfilled predefined expression criteria. In a larger cohort of patients and controls, a disease-associated expression pattern, with higher transcript levels in vitamin D-treated PBMCs from patients, was observed for three of these genes, CLEC5A (P < 0.030), lysozyme (LYZ; P < 0.047) and TREM1 (P < 0.023). Six genes were found to be expressed in a NOD2-dependent manner (CD101, P < 0.002; CLEC5A, P < 0.020; CXCL5, P < 0.009; IL-24, P < 0.044; ITGB2, P < 0.041; LYZ, P < 0.042). Interestingly, the highest transcript levels were observed in patients with heterozygous NOD2 mutations. CONCLUSION: Our data identify CLEC5A and LYZ as CD- and NOD2-associated genes of PBMCs and encourage further studies on their pathomechanistic roles.
format Online
Article
Text
id pubmed-5859222
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-58592222018-03-22 NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients Schäffler, Holger Rohde, Maria Rohde, Sarah Huth, Astrid Gittel, Nicole Hollborn, Hannes Koczan, Dirk Glass, Änne Lamprecht, Georg Jaster, Robert World J Gastroenterol Basic Study AIM: To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn’s disease (CD) patients in clinical remission. METHODS: Patients with CD in clinical remission or with very low disease activity according to the Crohn’s disease activity index were genotyped regarding nucleotide-binding oligomerization domain 2 (NOD2), and PBMCs from wild-type (WT)-NOD2 patients, patients with homozygous or heterozygous NOD2 mutations and healthy donors were isolated for further analysis. The cells were cultured with vitamin D, peptidoglycan (PGN) and lipopolysaccharide (LPS) for defined periods of time before RNA was isolated and subjected to microarray analysis using Clariom S assays and quantitative real-time PCR. NOD2- and disease-specific gene expression profiles were evaluated with repeated measure ANOVA by a general linear model. RESULTS: Employing microarray assays, a total of 267 genes were identified that were significantly up- or downregulated in PBMCs of WT-NOD2 patients, compared to healthy donors after challenge with vitamin D and/or a combination of LPS and PGN (P < 0.05; threshold: ≥ 2-fold change). For further analysis by real-time PCR, genes with known impact on inflammation and immunity were selected that fulfilled predefined expression criteria. In a larger cohort of patients and controls, a disease-associated expression pattern, with higher transcript levels in vitamin D-treated PBMCs from patients, was observed for three of these genes, CLEC5A (P < 0.030), lysozyme (LYZ; P < 0.047) and TREM1 (P < 0.023). Six genes were found to be expressed in a NOD2-dependent manner (CD101, P < 0.002; CLEC5A, P < 0.020; CXCL5, P < 0.009; IL-24, P < 0.044; ITGB2, P < 0.041; LYZ, P < 0.042). Interestingly, the highest transcript levels were observed in patients with heterozygous NOD2 mutations. CONCLUSION: Our data identify CLEC5A and LYZ as CD- and NOD2-associated genes of PBMCs and encourage further studies on their pathomechanistic roles. Baishideng Publishing Group Inc 2018-03-21 2018-03-21 /pmc/articles/PMC5859222/ /pubmed/29568200 http://dx.doi.org/10.3748/wjg.v24.i11.1196 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Basic Study
Schäffler, Holger
Rohde, Maria
Rohde, Sarah
Huth, Astrid
Gittel, Nicole
Hollborn, Hannes
Koczan, Dirk
Glass, Änne
Lamprecht, Georg
Jaster, Robert
NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
title NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
title_full NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
title_fullStr NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
title_full_unstemmed NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
title_short NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
title_sort nod2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from crohn’s disease patients
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859222/
https://www.ncbi.nlm.nih.gov/pubmed/29568200
http://dx.doi.org/10.3748/wjg.v24.i11.1196
work_keys_str_mv AT schafflerholger nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT rohdemaria nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT rohdesarah nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT huthastrid nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT gittelnicole nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT hollbornhannes nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT koczandirk nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT glassanne nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT lamprechtgeorg nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients
AT jasterrobert nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients